<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Summers, Jaye</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Beale, Richard</style></author><author><style face="normal" font="default" size="100%">Van Zanten, Arthur</style></author><author><style face="normal" font="default" size="100%">Wischmeyer, Paul</style></author><author><style face="normal" font="default" size="100%">Deane, Adam</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Late-Breaking Topics in Clinical Nutrition</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">6-8</style></pages><abstract><style  face="normal" font="default" size="100%">In critically ill patients, the CALORIES trial showed no significant difference between 2 feeding methods on all-cause mortality; the MetaPlus trial results suggest no benefit from administration of an immune-enhanced enteral formula; in the TARGET trial, a higher-density enteral formula led to higher daily caloric intakes; and results from the ICU Microbiome Project indicate that loss of microbiome diversity may lead to poor clinical outcomes.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>